Symbicort is a prescription drug used to treat asthma and chronic obstructive pulmonary disease (COPD). Learn how to lower long-term costs and more.

Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain ...

Symbicort is a prescription drug used to treat asthma and COPD. Learn about side effects and how to manage them.

Breyna (budesonide and formoterol fumarate dihydrate) inhalation aerosol, the first generic version of Symbicort, is now available.

The first Symbicort generic, simply referred to as budesonide/formoterol inhaler, was approved by the Food and Drug Administration (FDA) in February 2020 and is roughly half the cost of Symbicort ...

Viatris and Kindeva Drug Delivery could soon launch a generic version of AstraZeneca's Symbicort.

Viatris' Mylan Pharmaceuticals Inc cleared a hurdle Wednesday in a bid to launch a generic version of AstraZeneca AB's blockbuster asthma drug Symbicort, persuading a West Virginia federal court ...

Viatris and Kindeva declared victory over a fourth patent on AZ’s drug-device combo Symbicort, which brought home more than $2.7 billion in sales for the British pharma last year.

This extended the lapse date of a key patent for Symbicort to July 2023. But with just six months until that patent expires, Viatris could soon launch its generic version of Symbicort, known as ...